| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 04/17/1997 | WO1997003203A3 Generation of immune responses to prostate-specific antigen (psa) |
| 04/17/1997 | WO1996017072A3 Recombinant alphavirus vectors |
| 04/17/1997 | CA2234604A1 Recombinant herpes virus vectors for expression in neuronal cells |
| 04/17/1997 | CA2233313A1 Methods to identify modulators of cell signaling |
| 04/17/1997 | CA2232155A1 Improvements in or relating to protection against intracellular infection |
| 04/17/1997 | CA2231547A1 Liposomal compositions and methods of using them |
| 04/16/1997 | EP0767840A2 Method for introducing foreign matter into higher eukaryotic cells |
| 04/16/1997 | EP0767839A1 Improvements in or relating to delivery of nucleic acids |
| 04/16/1997 | EP0767796A1 Monocyte chemotactic protein-4 |
| 04/16/1997 | CN1147837A Recombinant adenoviral vector and methods of use |
| 04/16/1997 | CN1147834A Coordinate in vivo gene expression |
| 04/16/1997 | CN1147768A Compositions comprising DNA damaging agents and P53 |
| 04/16/1997 | CN1147554A Muscular expression plasmid of vessel endothelium growth factor gene and its construction and application |
| 04/15/1997 | US5620896 Genetic engineering |
| 04/10/1997 | WO1997012986A2 Non-group c adenoviral vectors |
| 04/10/1997 | WO1997012985A2 Multi-functional hematopoietic receptor agonists |
| 04/10/1997 | WO1997012979A1 Interleuken-3 (il-3) receptor agonists |
| 04/10/1997 | WO1997012978A1 NOVEL c-mpl RECEPTOR AGONISTS |
| 04/10/1997 | WO1997012972A2 Regulated genes and uses thereof |
| 04/10/1997 | WO1997012970A1 Antitumour vector constructs and methods |
| 04/10/1997 | WO1997012969A2 Fmr1-related protein |
| 04/10/1997 | WO1997012635A1 Method for treating amyotrophic lateral sclerosis |
| 04/10/1997 | WO1997012623A1 Methods and compositions for viral enhancement of cell killing |
| 04/10/1997 | WO1997012622A1 Vector and method of use for nucleic acid delivery to non-dividing cells |
| 04/10/1997 | WO1997012617A1 Proteins involved in targeting of peptidyl transfer center, and corresponding therapeutic agents and methods |
| 04/10/1997 | WO1997012519A1 Treatment of vascular injury |
| 04/10/1997 | CA2234229A1 Proteins involved in targeting of peptidyl transfer center, and corresponding therapeutic agents and methods |
| 04/10/1997 | CA2234061A1 Multi-functional hematopoietic receptor agonists |
| 04/10/1997 | CA2234060A1 Methods and compositions for viral enhancement of cell killing |
| 04/10/1997 | CA2234059A1 Novel c-mpl receptor agonists |
| 04/10/1997 | CA2234045A1 Interleuken-3 (il-3) receptor agonists |
| 04/10/1997 | CA2233499A1 Treatment of vascular injury |
| 04/10/1997 | CA2233296A1 Compound having sequence homology with lipoprotein associated phospholipase a2 (lp-pla2)/paf acetyl hydrolase |
| 04/10/1997 | CA2230957A1 Regulated genes and uses thereof |
| 04/09/1997 | EP0766693A1 Novel parasite protease genes and proteins |
| 04/09/1997 | EP0766570A1 Methods for treating respiratory disease |
| 04/09/1997 | EP0766569A1 Aav capsid vehicles for molecular transfer |
| 04/09/1997 | EP0766512A1 Replication-competent herpes simplex virus mediates destruction of neoplastic cells |
| 04/09/1997 | EP0348458B1 Dna molecules stabilized by modifications of the 3'-terminal phosphodiester linkage and their use as nucleic acid probes and as therapeutic agents to block the expression of specifically targeted genes |
| 04/08/1997 | US5618921 Antibodies for detection of human MDM2 protein |
| 04/08/1997 | US5618717 DNA encoding human AlkB |
| 04/08/1997 | US5618531 Method for increasing the viability of cells which are administered to the brain or spinal cord |
| 04/03/1997 | WO1997012060A1 ARF-p19, A NOVEL REGULATOR OF THE MAMMALIAN CELL CYCLE |
| 04/03/1997 | WO1997012055A1 Product and process to regulate actin polymerization |
| 04/03/1997 | WO1997012052A1 Transduction of hematopoietic cells by viral vector and a cationic lipid |
| 04/03/1997 | WO1997012051A1 Pharmaceutical composition useful for nucleic acid transfection, and use thereof |
| 04/03/1997 | WO1997012050A1 Method for transferring genes to the heart using aav vectors |
| 04/03/1997 | WO1997012049A1 Materials and methods relating to the transfer of nucleic acid into quiescent cells |
| 04/03/1997 | WO1997012048A1 Recombinant viruses incorporating a protease cleavable protein |
| 04/03/1997 | WO1997012040A1 GENE THERAPY WITH MODIFIED p65 PROTEINS |
| 04/03/1997 | WO1997012035A2 Transgenic animals for xenotransplantation with reduced antibody-mediated rejection |
| 04/03/1997 | WO1997011970A1 Cytostatin ii |
| 04/03/1997 | WO1997011968A2 A gene associated with liver neoplastic disease |
| 04/03/1997 | WO1997011956A1 IDENTIFICATION OF sel-12 AND USES THEREOF |
| 04/03/1997 | WO1997011720A1 Methods for treating cancers and restenosis with p21 |
| 04/03/1997 | WO1997011716A1 Manipulation of non-terminally differentiated cells using the notch pathway |
| 04/03/1997 | WO1997011682A2 Emulsion and micellar formulations for the delivery of biologically active substances to cells |
| 04/03/1997 | WO1997011607A1 Method of inhibiting immune system destruction of transplanted viable cells |
| 04/03/1997 | WO1997011605A1 Stimulation of cell-mediated immune responses by targeted particulate genetic immunization |
| 04/03/1997 | WO1997011604A1 Methods for enhanced virus-mediated dna transfer using molecules with virus- and cell-binding domains |
| 04/03/1997 | WO1997003192A3 Chromosome 1 gene and gene products related to alzheimer's disease |
| 04/03/1997 | WO1997001634A3 Polypeptide for repairing genetic information, nucleotidic sequence which codes for it and process for the preparation thereof (guanine thymine binding protein - gtbp) |
| 04/03/1997 | WO1996040948A3 Resistance to viruses and viroids in transgenic plant and animal hosts expressing dsrna-binding protein |
| 04/03/1997 | WO1996039516A3 Targets for breast cancer diagnosis and treatment |
| 04/03/1997 | CA2233297A1 Identification of sel-12 and uses thereof |
| 04/03/1997 | CA2233278A1 Stimulation of cell-mediated immune responses by targeted particulate genetic immunization |
| 04/03/1997 | CA2233167A1 Method for transferring genes to the heart using aav vectors |
| 04/03/1997 | CA2233040A1 Transgenic animals for xenotransplantation with reduced antibody-mediated rejection |
| 04/03/1997 | CA2233031A1 Gene therapy with modified p65 proteins |
| 04/03/1997 | CA2232815A1 Method of inhibiting immune system destruction of transplanted viable cells |
| 04/03/1997 | CA2232669A1 Recombinant viruses incorporating a protease cleavable protein |
| 04/03/1997 | CA2231735A1 Materials and methods relating to the transfer of nucleic acid into quiescent cells |
| 04/03/1997 | CA2231064A1 Pharmaceutical composition useful for nucleic acid transfection, and use thereof |
| 04/03/1997 | CA2230940A1 Emulsion and micellar formulations for the delivery of biologically active substances to cells |
| 04/03/1997 | CA2230121A1 Product and process to regulate actin polymerization |
| 04/02/1997 | EP0765396A1 Locus control subregions for integration-site independent transgene expression |
| 04/02/1997 | EP0670735B1 Peripheralization of hematopoietic stem cells |
| 04/02/1997 | CN1146712A Myoblast therapy for mammalian diseases |
| 04/01/1997 | US5616490 Enzymatic rna molecule which specifically cleaves messenger rna produced from gene encoding tumor necrosis factor-alpha; treating psoriasis |
| 04/01/1997 | US5616488 IL-5 targeted ribozymes |
| 04/01/1997 | US5616487 Alpha-hydro-omega-hydroxypoly(oxyethylene)polyoxypropylene block copolymer; introducing an exogenous nucleotide sequence into target cell |
| 03/27/1997 | WO1997011191A1 Method of transgene expression and secretion in schistosoma |
| 03/27/1997 | WO1997011190A2 Dna construct comprising a muscle specific regulatory element for immunization or gene therapy |
| 03/27/1997 | WO1997011182A1 New adhesin from helicobacter pylori |
| 03/27/1997 | WO1997011177A1 Neutralizing monoclonal antibodies to respiratory syncytial virus |
| 03/27/1997 | WO1997011176A2 Cyclin/cdk associated proteins, and uses related thereto |
| 03/27/1997 | WO1997011171A1 Modified protein kinase a-specific oligonucleotides and methods of their use |
| 03/27/1997 | WO1997011169A2 Strategy for suppressing the expression of an endogeneous gene by using compounds that are able to bind to the non-coding regions of the gene to be suppressed |
| 03/27/1997 | WO1997011168A1 Promoter and uses thereof |
| 03/27/1997 | WO1997011163A1 Pskh-1 ribozymes and uses in disease treatment |
| 03/27/1997 | WO1997011089A1 Treatment of patients with idiopathic dilated cardiomyopathy |
| 03/27/1997 | WO1997010851A2 Nucleic acid delivery vehicle |
| 03/27/1997 | WO1997010846A1 Neutralizing monoclonal antibodies to respiratory syncytial virus |
| 03/27/1997 | WO1997010843A1 Modified p53 constructs and uses therefor |
| 03/27/1997 | WO1997010840A1 Anti-inflammatory antisense drug |
| 03/27/1997 | WO1997010796A2 MANIPULATION AND DETECTION OF PROTEIN PHOSPHATASE 2C - PP2Cα - EXPRESSION IN TUMOR CELLS FOR CANCER THERAPY, PREVENTION AND DETECTION |
| 03/27/1997 | DE19535321A1 Neues Adhäsin aus Helicobacter pylori Create an adhesin of Helicobacter pylori |
| 03/27/1997 | CA2232730A1 New adhesin from helicobacter pylori |
| 03/27/1997 | CA2232724A1 Modified protein kinase a-specific oligonucleotides and methods of their use |
| 03/27/1997 | CA2232514A1 Method of transgene expression and secretion in schistosoma |